News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
Presentation TCT 2018 Is There a Role for Invasive Physiology in Acute Coronary Syndromes? Presenter: Anibal A. Damonte, Jacques Monsegu, Patrick Dupouy September 24, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
News Daily News Respiratory Syncytial Virus Linked With Cardiovascular Complications Michael O'Riordan April 04, 2018
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings Shelley Wood January 19, 2017
News Features Be It Resolved: As Evidence Mounts in Favor of a Brain-Heart Connection, Stress Should Be on the Radar During CVD Diagnosis Yael L. Maxwell January 16, 2017
News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Industry News Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure June 13, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Daily News Europeans Issue Guidance on Direct Discharge of Acute Heart Failure Patients From ED Todd Neale February 23, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Industry News First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit June 09, 2015
News Daily News La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban Todd Neale January 28, 2015
News Daily News HF Worsens Outcomes Following ACS, With No Benefit From Apixaban Todd Neale January 28, 2015
News Daily News Meta-analysis: Heart Failure Worsens Short-term Prognosis of NSTE-ACS Patients June 28, 2013